InvestorsHub Logo
Followers 4
Posts 702
Boards Moderated 0
Alias Born 05/19/2016

Re: None

Monday, 08/07/2017 9:33:56 AM

Monday, August 07, 2017 9:33:56 AM

Post# of 471363
"The respective trial designs are based on broad genomic and biomarker characterization, pharmacokinetic and pharmacodynamic modeling including data from patients in previous ANAVEX™ 2-73 trials, as well as preclinical translational science."

The trials are already designed...past tense. We are very close indeed.

Standby for ignition.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News